Vancomycin and linear IgA bullous dermatosis
Vancomycin is a broad-spectrum antibiotic that is considered an optimal parenteral treatment for many infections, including septicemia, pneumonia, cellulitis, endocarditis, and meningitis caused by methicillin-resistant Staphylococcus aureus. It is the first-line treatment for the increasing health...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Southwest Respiratory and Critical Care Chronicles
2018-01-01
|
Series: | Southwest Respiratory and Critical Care Chronicles |
Subjects: | |
Online Access: | http://www.pulmonarychronicles.com/index.php/pulmonarychronicles/article/view/445 |
Summary: | Vancomycin is a broad-spectrum antibiotic that is considered an optimal parenteral
treatment for many infections, including septicemia, pneumonia, cellulitis, endocarditis, and
meningitis caused by methicillin-resistant Staphylococcus aureus. It is the first-line treatment
for the increasing health care-associated infection Clostridium difficile pseudomembranous
colitis. More side effects are being reported secondary to increased vancomycin use. Of those
side effects, skin reactions are becoming more recognized by physicians. |
---|---|
ISSN: | 2325-9205 |